Seer, Inc.
General ticker "SEER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $127.8M (TTM average)
Seer, Inc. follows the US Stock Market performance with the rate: 0.4%.
Estimated limits based on current volatility of 2.7%: low 1.94$, high 2.05$
Factors to consider:
- Total employees count: 134 (-8.8%) as of 2024
- Top business risk factors: Early stage company with historical losses, Limited operating history, Market acceptance of proteograph, Fluctuating operating results, Pandemic risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.26$, 2.92$]
- 2026-12-31 to 2027-12-31 estimated range: [1.28$, 2.95$]
Financial Metrics affecting the SEER estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -42.46 <= 0.07
- Positive: Investing cash flow per share per price, % of 58.80 > -0.65
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of -2.14 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SEER quotes
Long-term SEER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $15.18MM | $14.17MM | $16.58MM |
| Operating Expenses | $120.12MM | $114.27MM | $94.57MM |
| Operating Income | $-104.94MM | $-100.10MM | $-77.99MM |
| Non-Operating Income | $18.66MM | $13.60MM | $4.59MM |
| R&D Expense | $47.44MM | $50.59MM | $43.87MM |
| Income(Loss) | $-86.28MM | $-86.50MM | $-73.40MM |
| Taxes | $0.00MM | $0.10MM | $0.20MM |
| Profit(Loss)* | $-86.28MM | $-86.60MM | $-73.60MM |
| Stockholders Equity | $396.90MM | $327.57MM | $259.31MM |
| Inventory | $4.49MM | $7.44MM | $7.79MM |
| Assets | $436.27MM | $366.60MM | $296.08MM |
| Operating Cash Flow | $-59.06MM | $-46.11MM | $-44.45MM |
| Capital expenditure | $7.31MM | $3.58MM | $1.80MM |
| Investing Cash Flow | $37.90MM | $65.86MM | $61.55MM |
| Financing Cash Flow | $0.45MM | $-11.49MM | $-10.57MM |
| Earnings Per Share** | $-1.35 | $-1.39 | $-1.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.